Toolkit/AlphaFold3

AlphaFold3

Computational Method·Research·Since 2025

Also known as: AlphaFold 3, AlphaFold3

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

AlphaFold3 is a computational structure-prediction method used in the cited study to model the MagMboI–DNA complex. In that work, it was applied to infer interactions with the 5'-GATC-3' recognition sequence and to guide optimization of the photoactivatable endonuclease variant MagMboI-plus for top-down genome engineering.

Usefulness & Problems

Why this is useful

In the cited study, AlphaFold3 was useful for generating a structural model of a protein–DNA complex that informed interpretation of sequence recognition by MagMboI. This enabled structure-guided optimization of a photoactivatable nuclease in the absence of other evidence described here.

Problem solved

The specific problem addressed in the cited work was how to rationalize MagMboI recognition of the 5'-GATC-3' DNA sequence and use that information to improve a photoactivatable endonuclease variant. The available evidence does not provide broader benchmarking or general performance claims for AlphaFold3 beyond this application.

Published Workflows

Objective: Identify RNA conformational states consistent with experimental smFRET data from a heterogeneous and difficult-to-predict RNA system.

Why it works: The workflow first generates a collection of candidate RNA conformations, removes structurally implausible models, then predicts dye-pair FRET distributions for retained structures and compares them to experimental smFRET data to identify compatible conformational states.

matching predicted FRET distributions to experimental smFRET statesretaining models consistent with Watson-Crick base-pairing patternsmulti-tool RNA 3D structure predictionstructural validation and eRMSD filteringaccessible contact volume calculationcomparison and weighting against experimental smFRET data

Stages

  1. 1.
    Candidate RNA 3D structure generation(library_design)

    This stage creates the initial collection of candidate RNA conformations needed for downstream structural validation and FRET-guided selection.

    Selection: Generate a collection of candidate conformations using three RNA 3D modeling tools.

  2. 2.
    Structural validation and eRMSD filtering(in_silico_filter)

    This stage removes models that fail structural validation before computational FRET prediction.

    Selection: Watson-Crick base-pairing patterns and an eRMSD threshold

  3. 3.
    FRET distribution prediction for retained structures(secondary_characterization)

    This stage converts retained structures into predicted observables that can be compared with experiment.

    Selection: Compute accessible contact volume of the Cy3/Cy5 dye pair using FRETraj to predict FRET distributions.

  4. 4.
    Comparison and weighting against experimental smFRET data(confirmatory_validation)

    This stage identifies conformational states compatible with the observed FRET states.

    Selection: Agreement of predicted FRET distributions with experimental smFRET data

Steps

  1. 1.
    Predict candidate RNA 3D structures with three modeling toolscandidate structure generators

    Generate a collection of candidate conformations for the target ribosomal RNA tertiary contact.

    Candidate structures are required before any structural validation, filtering, or FRET back-calculation can occur.

  2. 2.
    Validate candidate structures by Watson-Crick base-pairing patterns and filter by eRMSD threshold

    Retain structurally plausible models for downstream FRET prediction.

    Structural filtering is performed before FRET prediction so only retained structures are subjected to the more specific comparison against experimental data.

  3. 3.
    Compute Cy3/Cy5 accessible contact volumes and predict FRET distributions with FRETrajFRET back-calculation method

    Translate retained structures into predicted FRET distributions.

    FRET prediction is done after structural filtering because the abstract states it is performed for each retained structure.

  4. 4.
    Compare and weight predicted FRET distributions against experimental smFRET data

    Identify conformational states compatible with the observed FRET states.

    This final comparison uses the predicted observables from the previous step to select experimentally compatible conformational states.

Objective: Integrate experimental cryo-EM data with AI-based structure prediction to accelerate protein structure-function analysis and modeling of challenging targets.

Why it works: The review describes cryo-EM and AI as complementary, with cryo-EM providing experimental structural information and AI providing accurate computational predictions from sequence.

near-atomic experimental visualizationsequence-to-structure predictionmap-guided model integrationcryo-EMadvanced image processingdeep learning structure prediction

Objective: Optimize a photoactivatable restriction enzyme for light-controlled top-down genome engineering using AlphaFold3-guided structural redesign.

Why it works: The workflow uses structural modeling of the MagMboI-DNA complex to identify split-site changes expected to improve interface area, complex stability, and protein-DNA contacts, then tests whether those predicted improvements translate into in vivo activity under blue light control.

blue-light-induced heterodimerization restores nuclease activityincreased MagMboI-DNA interface areastrengthened protein-DNA contactspreserved alpha-helical integrityAlphaFold3 structural modelingcomparison of neighboring split-site variantsin vivo testing in Saccharomyces cerevisiae

Stages

  1. 1.
    AlphaFold3 modeling of the MagMboI-DNA complex(in_silico_filter)

    This stage provides structure-based insight to guide redesign before experimental testing.

    Selection: structural insights into interaction between MagMboI and its target DNA recognition sequence required for Mg2+-dependent DNA cleavage

  2. 2.
    Comparison of neighboring split-site variants(hit_picking)

    This stage narrows candidate split designs to a redesigned variant predicted to improve structural and functional properties.

    Selection: identification of an alternative split that increases interface area and enhances complex stability relative to the original construct

  3. 3.
    In vivo evaluation in Saccharomyces cerevisiae(confirmatory_validation)

    This stage tests whether structure-guided redesign improves in vivo function and reveals tradeoffs not captured by structural prediction alone.

    Selection: comparison of blue-light-activated DNA-cleavage activity and genomic rearrangements between MagMboI-plus and the original MagMboI construct

Steps

  1. 1.
    Model the MagMboI-DNA complex with AlphaFold3engineered nuclease modeled with a computation method

    Obtain structural insight into how MagMboI interacts with its target DNA recognition sequence.

    Structural modeling is performed first to guide redesign before selecting alternative split sites for experimental comparison.

  2. 2.
    Compare neighboring split-site variants to identify an alternative splitoriginal construct and redesigned variant

    Identify a split-site redesign predicted to improve interface area, stability, and protein-DNA contacts.

    Variant comparison follows structural modeling because the model provides the rationale for which split-site changes may improve the construct.

  3. 3.
    Test MagMboI-plus in Saccharomyces cerevisiae under blue light activationredesigned variant benchmarked against original construct

    Determine whether the redesigned variant improves in vivo DNA-cleavage activity and assess genome rearrangement consequences.

    In vivo testing is done after redesign selection to confirm whether predicted structural improvements translate into useful cellular performance and to detect liabilities.

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete computational method used to design, rank, or analyze an engineered system.

Target processes

editing

Input: Light

Implementation Constraints

The reported implementation involved modeling a MagMboI–DNA complex containing the 5'-GATC-3' recognition sequence to infer interactions relevant to Mg2+-dependent cleavage. The downstream biological validation was performed in Saccharomyces cerevisiae using a photoactivatable endonuclease system, but no additional practical details on software setup or input requirements are provided in the supplied evidence.

The supplied evidence is limited to a single 2025 study and one application context involving MagMboI optimization. No independent replication, quantitative accuracy metrics, runtime information, or comparisons to alternative structure-prediction methods are provided here.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1engineering strategysupports2026Source 2needs review

Next-generation countermeasures for Bt resistance include synergistic Cry/Vip pyramiding, CRISPR/Cas9-validated receptor knockouts revealing functional redundancy, Domain III chimerization, PACE, and AlphaFold3-guided rational redesign.

Countermeasures now integrate synergistic Cry/Vip pyramiding, CRISPR/Cas9-validated receptor knockouts revealing functional redundancy, Domain III chimerization (e.g., Cry1A.105), phage-assisted continuous evolution (PACE), and the emerging application of AlphaFold3 for structure-guided rational redesign of resistance-breaking variants.
Claim 2capability summarysupports2025Source 3needs review

Cryo-EM and AI-based structure prediction have revolutionized protein modeling by enabling near-atomic resolution visualization and highly accurate computational predictions from amino acid sequences.

Claim 3comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 4comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 5comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 6comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 7comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 8comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 9comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 10comparative liabilitysupports2025Source 1needs review

MagMboI-plus induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

genomic rearrangements more pronounced
Claim 11comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 12comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 13comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 14comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 15comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 16comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 17comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 18comparative performancesupports2025Source 1needs review

In Saccharomyces cerevisiae cells, MagMboI-plus showed slightly increased DNA-cleavage activity in vivo upon blue light activation compared with the original MagMboI construct.

DNA-cleavage activity change slightly increased
Claim 19complementaritysupports2025Source 3needs review

Cryo-EM and AI have complementary roles in modern protein structural biology.

Claim 20general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 21general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 22general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 23general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 24general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 25general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 26general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 27general strategysupports2025Source 1needs review

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Claim 28integration examplesupports2025Source 3needs review

AlphaFold predictions have been combined with cryo-EM maps to explore conformational diversity in cytochrome P450 enzymes.

Claim 29mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 30mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 31mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 32mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 33mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 34mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 35mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 36mechanismsupports2025Source 1needs review

MagMboI functions through a split-protein strategy in which blue-light-induced heterodimerization restores nuclease activity.

Claim 37structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 38structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 39structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 40structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 41structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 42structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 43structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 44structure guided designsupports2025Source 1needs review

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Claim 45tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 46tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 47tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 48tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 49tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 50tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 51tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 52tool descriptionsupports2025Source 1needs review

MagMboI is a photoactivatable restriction enzyme designed for light-controlled top-down genome engineering.

Claim 53use case scopesupports2025Source 3needs review

These technologies facilitate detailed insights into challenging protein targets including membrane proteins, flexible and intrinsically disordered proteins, and large macromolecular complexes.

Claim 54variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 55variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 56variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 57variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 58variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 59variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 60variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 61variant improvementsupports2025Source 1needs review

An alternative split-site variant, MagMboI-plus, increases the MagMboI-DNA interface area and enhances complex stability relative to the original construct.

Claim 62variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 63variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 64variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 65variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 66variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 67variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 68variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Claim 69variant propertysupports2025Source 1needs review

MagMboI-plus preserves alpha-helical integrity while strengthening protein-DNA contacts.

Approval Evidence

4 sources4 linked approval claimsfirst-pass slugs alphafold-3, alphafold3, alphafold3-guided-rational-redesign
the emerging application of AlphaFold3 for structure-guided rational redesign of resistance-breaking variants

Source:

We predicted 3D structures ... using three popular RNA 3D modeling tools, namely RNAComposer, FARFAR2, and AlphaFold3

Source:

Using AlphaFold3, we modeled the structure of the MagMboI-DNA complex and gained structural insights into the interaction between MagMboI and its target DNA recognition sequence (5'-GATC-3') required for Mg2+-dependent DNA cleavage.

Source:

We discuss the complementary roles of cryo-EM and AI, including developments in direct electron detectors, advanced image processing, and deep learning algorithms exemplified by AlphaFold 2 and the emerging AlphaFold 3.

Source:

engineering strategysupports

Next-generation countermeasures for Bt resistance include synergistic Cry/Vip pyramiding, CRISPR/Cas9-validated receptor knockouts revealing functional redundancy, Domain III chimerization, PACE, and AlphaFold3-guided rational redesign.

Countermeasures now integrate synergistic Cry/Vip pyramiding, CRISPR/Cas9-validated receptor knockouts revealing functional redundancy, Domain III chimerization (e.g., Cry1A.105), phage-assisted continuous evolution (PACE), and the emerging application of AlphaFold3 for structure-guided rational redesign of resistance-breaking variants.

Source:

method compositionsupports

Candidate RNA 3D conformations were generated using RNAComposer, FARFAR2, and AlphaFold3.

Source:

general strategysupports

AlphaFold3-based prediction can accelerate functional improvements in engineered enzymes and provide a strategy for developing light-controlled genome engineering tools.

Source:

structure guided designsupports

AlphaFold3 was used to model the MagMboI-DNA complex and provide structural insight into interaction with the 5'-GATC-3' recognition sequence required for Mg2+-dependent DNA cleavage.

Source:

Comparisons

Source-backed strengths

The cited study reports that AlphaFold3 supported modeling of the MagMboI–DNA complex and inference of contacts relevant to Mg2+-dependent DNA cleavage. In the resulting application, the AlphaFold3-guided MagMboI-plus construct induced more pronounced genomic rearrangements than the original MagMboI construct in Saccharomyces cerevisiae cells.

Ranked Citations

  1. 1.

    Seeded from load plan for claim c8. Extracted from this source document.

  2. 2.
    StructuralSource 2MED2026Claim 1

    Seeded from load plan for claim c4. Extracted from this source document.

  3. 3.

    Extracted from this source document.